Genetic Signatures Ltd (GSS) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.185x

Based on the latest financial reports, Genetic Signatures Ltd (GSS) has a cash flow conversion efficiency ratio of -0.185x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.25 Million ≈ $-6.54 Million USD) by net assets (AU$50.09 Million ≈ $35.44 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Genetic Signatures Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Genetic Signatures Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Genetic Signatures Ltd carry for a breakdown of total debt and financial obligations.

Genetic Signatures Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genetic Signatures Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nvni Group Limited Ordinary Shares NASDAQ:NVNI	0.049x
Harta Djaya Karya Tbk Pt JK:MEJA	0.151x
NSX Ltd AU:NSX	0.587x
oodash Group AB (publ) ST:OODA	N/A
Grupo Televisa SAB DRC BA:TV	0.045x
Sequoia Econ Infrastructure LSE:SEQI	0.026x
MSCM Holdings Bhd KLSE:0041	-0.048x
RECYCLICO BATTERY METALS F:ID4	N/A

Annual Cash Flow Conversion Efficiency for Genetic Signatures Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Genetic Signatures Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Genetic Signatures Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$50.09 Million ≈ $35.44 Million	AU$-12.29 Million ≈ $-8.70 Million	-0.245x	-48.12%
2024-06-30	AU$61.10 Million ≈ $43.23 Million	AU$-10.12 Million ≈ $-7.16 Million	-0.166x	+42.92%
2023-06-30	AU$42.91 Million ≈ $30.36 Million	AU$-12.45 Million ≈ $-8.81 Million	-0.290x	-262.15%
2022-06-30	AU$54.80 Million ≈ $38.78 Million	AU$9.81 Million ≈ $6.94 Million	0.179x	+110.46%
2021-06-30	AU$49.34 Million ≈ $34.91 Million	AU$4.20 Million ≈ $2.97 Million	0.085x	+141.13%
2020-06-30	AU$45.93 Million ≈ $32.50 Million	AU$-9.49 Million ≈ $-6.72 Million	-0.207x	+3.71%
2019-06-30	AU$10.57 Million ≈ $7.48 Million	AU$-2.27 Million ≈ $-1.61 Million	-0.215x	+22.12%
2018-06-30	AU$13.40 Million ≈ $9.48 Million	AU$-3.69 Million ≈ $-2.61 Million	-0.276x	-76.69%
2017-06-30	AU$16.49 Million ≈ $11.66 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.156x	+71.62%
2016-06-30	AU$4.68 Million ≈ $3.31 Million	AU$-2.57 Million ≈ $-1.82 Million	-0.550x	-38.78%
2015-06-30	AU$7.06 Million ≈ $4.99 Million	AU$-2.80 Million ≈ $-1.98 Million	-0.396x	-372.97%
2014-06-30	AU$16.18 Million ≈ $11.45 Million	AU$-1.35 Million ≈ $-958.56K	-0.084x	-123.40%
2013-06-30	AU$-3.32 Million ≈ $-2.35 Million	AU$-1.19 Million ≈ $-839.81K	0.358x	--

About Genetic Signatures Ltd

AU:GSS Australia Diagnostics & Research

Market Cap

$14.14 Million

AU$19.99 Million AUD

Market Cap Rank

#26008 Global

#1223 in Australia

Share Price

AU$0.09

Change (1 day)

+7.32%

52-Week Range

AU$0.08 - AU$0.68

All Time High

AU$2.75